VEGFC and neoplasm: In a striatal tumor model, VEGF-C overexpression induces meningeal lymphangiogenesis, displaying a synergy effect with anti-PD-1/cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) therapy, which can be abolished by CCL21/CCR7 blockade [112].